Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
End Stage Renal Disease on Dialysis clinical trials
Every US clinical trial registered for End Stage Renal Disease on Dialysis — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
10 US clinical trials · 3 currently recruiting
The research picture
End Stage Renal Disease on Dialysis has 10 registered US clinical trials, 3 of them open to new participants right now — about 30% of the total.
- 3
- recruiting participants now
- 30%
- of trials open to enrollment
- 2
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Vanderbilt University Medical Center
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Comparing Surgical and Endovascular Arteriovenous Fistula Creation
University of California, Los Angeles
NCT05654103
Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
University of Illinois at Chicago
NCT07014111
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Yale University
NCT05671991
The Home Blood Pressure (BP) Trial
University of Washington
NCT05159999
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
Vanderbilt University Medical Center
NCT05735743
DIALYSIS-TIR Study
University of Texas Southwestern Medical Center
NCT06042153
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
Outset Medical
NCT05947708
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Sanifit Therapeutics S. A.
NCT04487301
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
Vanderbilt University Medical Center
NCT05003115
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
Diality
NCT06581393
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the End Stage Renal Disease on Dialysis Trial Landscape
ClinicalTrials.gov lists 10 US studies indexed under End Stage Renal Disease on Dialysis, and 3 of those are currently open to recruitment — roughly 30% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for End Stage Renal Disease on Dialysis shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 0 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for End Stage Renal Disease on Dialysis is led by Vanderbilt University Medical Center with 2 indexed trials, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 10 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for End Stage Renal Disease on Dialysis?
PlainTrial tracks 10 US clinical trials for End Stage Renal Disease on Dialysis, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for End Stage Renal Disease on Dialysis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.